A critical review of manual therapy use for headache disorders: Prevalence, profiles, motivations, communication and self-reported effectiveness by Moore, CS et al.
RESEARCH ARTICLE Open Access
A critical review of manual therapy use for
headache disorders: prevalence, profiles,
motivations, communication and
self-reported effectiveness
Craig S. Moore*, David W. Sibbritt and Jon Adams
Abstract
Background: Despite the expansion of conventional medical treatments for headache, many sufferers of common
recurrent headache disorders seek help outside of medical settings. The aim of this paper is to evaluate research
studies on the prevalence of patient use of manual therapies for the treatment of headache and the key factors
associated with this patient population.
Methods: This critical review of the peer-reviewed literature identified 35 papers reporting findings from new
empirical research regarding the prevalence, profiles, motivations, communication and self-reported effectiveness of
manual therapy use amongst those with headache disorders.
Results: While available data was limited and studies had considerable methodological limitations, the use of manual
therapy appears to be the most common non-medical treatment utilized for the management of common recurrent
headaches. The most common reason for choosing this type of treatment was seeking pain relief. While a high
percentage of these patients likely continue with concurrent medical care, around half may not be disclosing the use
of this treatment to their medical doctor.
Conclusions: There is a need for more rigorous public health and health services research in order to assess the role,
safety, utilization and financial costs associated with manual therapy treatment for headache. Primary healthcare
providers should be mindful of the use of this highly popular approach to headache management in order to help
facilitate safe, effective and coordinated care.
Keywords: Headache, Migraine, Tension headache, Cervicogenic headache, Manual therapy, Physical therapy,
Chiropractic, Osteopathy, Massage
Background
The co-occurrence of tension headache and migraine is
very high [1]. Respectively, they are the second and third
most common disorders worldwide with migraine ranking
as the seventh highest specific cause of disability globally
[2] and the sixteenth most commonly diagnosed condition
in the US [3]. These common recurrent headache disor-
ders place a considerable burden upon the personal
health, finances and work productivity of sufferers [3–5]
with migraine further complicated by an association with
cardiovascular and psychiatric co-morbidities [6, 7].
Preventative migraine drug treatments include analge-
sics, anticonvulsants, antidepressants and beta-blockers.
Preventative drug treatments for tension-type headaches
can include analgesics, NSAIDs, muscle relaxants and
botulinum toxin as well as anticonvulsants and antide-
pressants. While preventative drug treatments are suc-
cessful for a significant proportion of sufferers, headache
disorders are still reported as under-diagnosed and
under-treated within medical settings [8–16] with other
studies reporting sufferers can cease continuing with
preventative headache medications long-term [9, 17].
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There is a number of non-drug approaches also uti-
lized for the prevention of headaches. These include
psychological therapies such as cognitive behavioral
therapy, relaxation training and EMG (electromyog-
raphy) biofeedback. In addition, there is acupuncture,
nutritional supplementation (including magnesium, B12,
B6, and Coenzyme Q10) and physical therapies. The use
of physical therapies is significant, with one recent global
survey reporting physical therapy as the most frequently
used ‘alternative or complementary treatment’ for head-
ache disorders across many countries [18]. One of the
most common physical therapy interventions for head-
ache management is manual therapy (MT), [19–21]
which we define here as treatments including ‘spinal ma-
nipulation (as commonly performed by chiropractors,
osteopaths, and physical therapists), joint and spinal
mobilization, therapeutic massage, and other manipula-
tive and body-based therapies’ [22].
Positive results have been reported in many clinical
trials comparing MT to controls [23–27], other physical
therapies [28–30] and aspects of medical care [31–34].
More high quality research is needed however to assess
the efficacy of MT as a treatment for common recurrent
headaches. Recent systematic reviews of randomized
clinical trials of MT for the prevention of migraine
report a number of significant methodological short-
comings and the need for more high quality research be-
fore any firm conclusions can be made [35, 36]. Recent
reviews of MT trials for tension-type headache and cer-
vicogenic headache are cautious in reporting positive
outcomes and the strong need for further robust re-
search [37–41]. Despite the limited clinical evidence
there has been no critical review of the significant use of
MT by headache populations.
Methods
The aim of this study is to report from the peer-
reviewed literature; 1) the prevalence of MT use for the
treatment of common recurrent headaches and 2) fac-
tors associated with this use across several key themes.
The review further identifies key areas worthy of further
research in order to better inform clinical practice, edu-
cators and healthcare policy within this area.
Design
A comprehensive search of peer-reviewed articles pub-
lished in English between 2000 and 2015 reporting new
empirical research findings of key aspects of MT use
among patients with migraine and non-migraine headache
disorders was undertaken. Databases searched were MED-
LINE, AMED, CINAHL, EMBASE and EBSCO. The key
words and phrases used were: ‘headache’, ‘migraine’, ‘pri-
mary headache’, ‘cephalgia’, ‘chronic headache’ AND ‘man-
ual therapy’, ‘spinal manipulation’, ‘manipulative therapy’,
‘spinal mobilization’, ‘chiropractic’, ‘osteopathy’, ‘massage’,
‘physical therapy’ or ‘physiotherapy’AND then ‘prevalence’,
‘utilization’ or ‘profile’ was used for additional searches
against the previous terms. The database search was ac-
companied by a hand search of prominent peer-reviewed
journals. All authors accessed the reviewed literature
(data) and provided input to analysis.
Due to the focus of the review, literature reporting
randomized control trials and similar clinical research
designs were excluded as were articles identified as let-
ters, correspondence, editorials, case reports and com-
mentaries. Further searches were undertaken of the
bibliographies in the identified publications. All identi-
fied articles were screened and only those reporting new
empirical findings on MT use for headache in adults
were included in the review. Articles identified and se-
lected for the review were research manuscripts mostly
within epidemiological and health economics studies.
The review includes papers reporting MT use pooled
with the use of other therapies, but only where MT pa-
tients comprised a large proportion (as stated) of the in-
cluded study population. Results were imported into
Endnote X7 and duplicates removed.
Search outcomes, analyses and quality appraisal
Figure 1 outlines the literature search process. The initial
search identified 3286 articles, 35 of which met the in-
clusion criteria. Information from each article was orga-
nized into a review table (Table 1) to summarise the
findings of the included papers. Information is reported
under two selected headache groups and within each in-
dividual MT profession - chiropractic, physiotherapy,
osteopathy and massage therapy – where sufficient detail
was available.
An appraisal of the quality of the articles identified for
review was conducted using a quality scoring system
(Table 2) developed for the critical appraisal of health lit-
erature used for prevalence and incidence of health
problems [42] adapted from similar studies [43–45].
This scoring system was applicable to the majority of
study designs involving surveys and survey-based struc-
tured interviews (29 of the 35 papers) but was not ap-
plicable to a small number of included studies based
upon clinical records, secondary analysis or practitioner
characteristics.
Two separate authors (CM and JA) independently
searched and scored the articles. Score results were
compared and any differences were further discussed
and resolved by all the authors. The quality score of each
relevant article is reported in Table 3.
Results
The key findings of the 35 articles were grouped and
evaluated using a critical review approach adapted from
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previous research [46, 47]. Based on the limited informa-
tion available for other headache types, prevalence find-
ings are reported within one of two categories - either as
‘migraine’ for papers reporting studies where the popula-
tion was predominately or entirely made up of migraine
patients or as ‘headache’ for papers where the study
population was predominately other headache types
(including tension-type headaches, cluster headaches,
cervicogenic headache) and/or where the headache type
was not clearly stated. Ten papers reported findings
examining prevalence rates for the ‘migraine’ category
alone, 18 papers reported findings examining prevalence
for the ‘headache’ category alone and 3 papers reported
findings for both categories. Based on the nature of the
information available, prevalence use was categorised by
manual therapy providers. The extracted data was then
analysed and synthesized into four thematic categories:
prevalence; profile and motivations for MT use; concurrent
use and order of use of headache providers; and self-
reported evaluation of MT treatment outcomes.
Prevalence of MT use
Thirty-one of the reviewed articles with a minimum
sample size (>100) reported findings regarding preva-
lence of MT use. The prevalence of chiropractic use for
those with migraine ranged from 1.0 to 36.2% (mean:
14.4%) within the general population [19–21, 48–52]
and from 8.9 to 27.1% (mean: 18.0%) within headache-
clinic patient populations [53, 54]. The prevalence of
chiropractic use for those reported as headache ranged
from 4 to 28.0% (mean: 12.9%) within the general popu-
lation [20, 48, 51, 55–57]; ranged from 12.0 to 22.0%
(mean: 18.6%) within headache/pain clinic patient popu-
lations [58–60] and from 1.9 to 45.5% (mean: 9.8%)
within chiropractic patient populations [61–69].
The prevalence use of physiotherapy for those with mi-
graine ranged from 9.0 to 57.0% (mean: 24.7%) within the
general population [19, 20, 48, 52] and from 4.9 to 18.7%
(mean: 11.8%) within headache-clinic patient populations
[54, 70]. The prevalence use of physiotherapy for those re-
ported as headache ranged from 12.2 to 52.0% (mean:
Fig. 1 Flow chart of study selection









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Moore et al. BMC Neurology  (2017) 17:61 Page 5 of 11
32.1%) within the general population [20, 48] and from
27.8 to 35.0%% (mean: 31.4%) within headache/pain clinic
populations [60, 70].
Massage therapy use for those with migraine ranged
from 2.0 to 29.7% (mean: 15.6%) within the general popu-
lation [49, 50, 71] and from 10.1 to 56.4% (mean: 33.9%)
within headache-clinic populations [53, 54, 72, 73]. Mas-
sage/acupressure use for those reported as headache
within headache/pain clinic patient populations ranged
from 12.0 to 54.0% (mean: 32.5%) [58–60, 70].
Osteopathy use for those with migraine was reported
as 1% within the general population [49]; as 2.7% within
a headache-clinic patient population [53] and as 1.7%
within an osteopathy patient population [74]. For head-
ache the prevalence was 9% within a headache/pain clinic
population [60] and ranged from 2.7 to 10.0% (mean:
6.4%) within osteopathy patient populations [74, 75].
The combined prevalence rate of MT use across all
MT professions for those with migraine ranged from 1.0
to 57.0% (mean: 15.9%) within the general population;
ranged from 2.7 to 56.4% (mean: 18.4%) within
headache-clinic patient populations and was reported as
1.7% in one MT patient population. The combined
prevalence rate of MT use across all MT professions for
those reported as headache ranged from 4.0 to 52.0%
(mean: 17.7%) within the general population; ranged
from 9.0 to 54.0% (mean: 32.3%) within headache-clinic
patient populations and from 1.9 to 45.5% (mean: 9.25%)
within MT patient populations.
Profile and motivations for MT use
While patient socio-demographic profiles were not re-
ported within headache populations that were exclu-
sively using MT, several studies report these findings
where MT users made up a significant percentage of the
non-medical headache treatments utilized by the study
population (range 40% – 86%: mean 63%). While find-
ings varied for level of income [58, 70] and level of edu-
cation, [70, 72, 73] this patient group were more likely
to be older [70, 72], female [20], have a higher rate of co-
morbid conditions [58, 70, 76] and a higher rate of pre-
vious medical visits [20, 58, 70] when compared to the
non-user group. Overall, this group were reported to
have a higher level of headache chronicity or headache
disability than non-users [20, 54, 58, 70, 72, 77].
Several studies within headache-clinic populations report
patient motivations for the use of complementary and al-
ternative headache treatments where MT users made up a
significant proportion of the study population (range 40%
– 86%: mean 63%) [58, 70, 72, 78]. From these studies the
most common motivation reported by study patients was
‘seeking pain relief ’ for headache which accounted for
45.4% – 84.0% (mean: 60.5%) of responses. The second
most common motivation was patient concerns regarding
the ‘safety or side effects’ of medical headache treatment,
accounting for 27.2% – 53.0% (mean: 43.8%) of responses
[58, 70, 72]. ‘Dissatisfaction with medical care’ accounted
for 9.2% – 35.0% (mean: 26.1%) of responses [58, 70, 72].
A limited number of reviewed papers (all from Italy) re-
port on the source of either the referral or recommenda-
tion to MT for headache treatment [53, 58, 59]. From these
studies, referral from a GP to a chiropractor ranged from
50.0 to 60.8% (mean: 55.7%), while referral from friends/
relatives ranged from 33.0 to 43.8% (mean: 38.7%) and self-
recommendation ranged from 0 to 16.7% (mean: 5.6%).
For massage therapy, referral from a GP ranged from 23.2
to 50.0% (mean: 36.6%), while referral from friends/rela-
tives ranged from 38.4 to 42.3% (mean: 40.4%) and self-
recommendation ranged from 7.7 to 38.4% (mean: 23.1%).
For acupressure, referral from a GP ranged from 33.0 to
50.0% (mean: 41.5%), while referral from friends/relatives
was reported as 50% and self-recommendation ranged
from 0 to 16.6% (mean: 8.3%). One study reported findings
for osteopathy where referral from both GP’s and friends/
relatives was reported as 42.8% and self-recommendation
was reported as 14.4%. Overall, the highest proportion of
referrals within these studies was from GPs to chiroprac-
tors for chronic tension-type headache (56.2%), cluster
headache (50%) and migraine (60.8%).
Concurrent use and order of use of headache providers
and related communication of MT users
Several studies report on the concurrent use of medical
headache management with complementary and alternative
Table 2 Description of quality criteria and scoring for selected
studies
Dimensions of Quality Assessment Points Awarded†
Methodology
A. Sampling strategy reported/
appropriate to study design
1
B. Sample size >100 1
C. Response rate >75% 1
D. Low recall bias (prospective
data collection or retrospective data
collection within past 12 months)
1
Reporting of Participants characteristics
E. Classification of migraine or headache
type(s) reported
1
F. Age and sex 1
G. Ethnicity 1
H. Indicator of socioeconomic status
(income, education)
1
Reporting of relevant MT factors
I. Reporting of MT use for headache 1
J. Reporting of MT financial costs 1
†Maximum score of 10 points for studies applicable to this scoring system
with each item weighted equally with 0 (criterion not fulfilled) or 1 (criterion
fulfilled) point
Moore et al. BMC Neurology  (2017) 17:61 Page 6 of 11
therapies. In those studies where the largest percentage of
the patient population were users of MT’s (range 57.0% –
86.4%: mean 62.8%), [58, 70, 78] concurrent use of medical
care ranged between 29.5% and 79.0% (mean: 60.0%) of the
headache patient population.
These studies further report on the level of patient non-
disclosure to medical providers regarding the use of MT
for headache. Non-disclosure ranged between 25.5 and
72.0% (mean: 52.6%) of the patient population, with the
most common reason for non-disclosure reported as the
doctor ‘never asking’, ranging from 37.0 to 80.0% (mean:
58.5%). This was followed by a patient belief that ‘it was
not important for the doctor to know’ or ‘none of the
doctor’s business’, ranging from 10.0 to 49.8% (mean:
30.0%). This was followed by a belief that either ‘the doctor
would not understand’ or ‘would discourage’ these treat-
ments, ranging from 10.0 to 13.0% (mean: 11.5%) [53, 77].
One large international study reported the ordering of
the typical provider of headache care by comparing find-
ings between several countries for migraine patients
[21]. Primary care providers followed by neurologists
were reported as the first and second providers for mi-
graine treatment for nearly all countries examined. The
only exception was Australia, where those with chronic
migraine selected chiropractors as typical providers at
equal frequency to neurologists (14% for both) while
Table 3 Quality score for selected studies
Dimensions of Quality Assessment
Authors/Year Methodology Participant characteristics Reporting of MT use Total score
Ailliet et al, 2010 [65] A, B, C F, H I 6
Bigal et al, 2008 [19] A, B, C, D E, F, G, H 8
Brown et al, 2013 [69] A, B, C, D F, H 6
Brown et al, 2014 [61] A, B, C, D F, G, H I 8
Cherkin et al, 2002 [62] A, B, C, D F, G I 7
Cooke et al, 2010 [49] A, B, D E, F, 5
Coulter et al, 2002 [66] A, B, D F, G, H 6
French et al, 2013 [64] A, B, D F, G, H I 7
Gaul et al, 2009 [70] A, B, D E, F, G, H I 8
Gaul et al, 2011 [72] A, B, D E, F, H I 7
Gaumer G, 2006 [56] A, B, D F, H 5
Goksel et al, 2014 [73] A, B, D E, F, H I 7
Hartvigsen el al, 2003 [68] A, B, C, D 4
Kristofferson et al, 2012 [20] A, B, E, F, G I 6
Kristoffersen et al, 2013 [79] A, B, D E, F, I 6
Lambert et al, 2010 [77] A, D F, G, H I 6
Lyngberg et al, 2005 [1, 52] A, B, C, D E, F 6
Malone et al, 2015 [71] B, C, D F, 4
Ossendorf et al, 2009 [60] A, B, C, D F, H I 7
Rossi et al, 2005 [53] A, B, D E, F, H, I 7
Rossi et al, 2006 [58] A, B, D, E, F, H I 7
Rossi et al, 2008 [59] A, B, C, D E, F, H 7
Rubinstein et al, 2000 [67] A, B, C, D F, H 6
Sanderson et al, 2013 [21] A, B, C, D E, F, G, H 8
S von Peter et al, 2002 [78] C, D E, F, G, H I 7
Vukovic et al, 2010 [48] A, B, C, D E, F, 6
Wells et al, 2010 [51] A, B, D F, G, H 6
Wells et al, 2011 [50] A, B, D F, G, H I 7
Xue et al, 2008 [55] A, B, D F, G, H 6
Key: A-Sampling reported, B-Sample size >100, C-Response rate >75%, D-Low recall bias, E-Classification of headache type, F-Age and sex, G-Ethnicity, H-Socioeconomic
status Scoring: 1-4 poor quality, 5-6 low quality, 7-8 moderate quality, 9-10 high quality
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those with episodic migraine selected chiropractors at a
greater frequency to neurologists (13% versus 5%). Com-
paratively, chiropractors were selected as the typical pro-
vider for those with chronic migraine by 10% in USA and
Canada, 1% in Germany and 0% for UK and France. Chi-
ropractors were selected as the typical provider for those
with episodic migraine by 7% in USA, 6% in Germany, 4%
in Canada and by 1% in both the UK and France.
Self-reported effectiveness of MT treatment outcomes
Several headache and pain-clinic population studies pro-
vide findings for the self-reported effectiveness of MT
headache treatment. For chiropractic, patient self-reporting
of partially effective or fully effective headache relief ranged
from 27.0 to 82.0% (mean: 45.0%) [53, 58–60, 78]. For mas-
sage therapy, patient self-reporting of partially effective or
fully effective headache relief ranged from 33.0 to 64.5%
(mean: 45.2%)[53, 58, 60, 73, 78], and for acupressure this
ranged from 33.4 to 50.0% (mean: 44.5%) [53, 58, 59]. For
osteopathy and physiotherapy, one study reported effect-
iveness as 17 and 36% respectively [60].
When results are combined across all MT profes-
sions the reporting of MT as either partially or fully
effective ranged from 17.0 to 82.0% (mean 42.5%)
[53, 58–60, 73, 78]. In addition, one general popula-
tion study provides findings for the self-reported effect-
iveness for chiropractic and physiotherapy at 25.6 and
25.1% respectively for those with primary chronic head-
ache and 38 and 38% respectively for those with secondary
chronic headache [79].
Discussion
This paper provides the first critical integrative review on
the prevalence and key factors associated with the use of
MT treatment for headaches within the peer-reviewed lit-
erature. While study methodological limitations and lack
of data prevent making strong conclusions, these findings
raise awareness of issues of importance to policy-makers,
educators, headache providers and future research.
Our review found that MT use was generally higher
within medical headache-clinic populations when com-
pared to general populations. However, the use of indi-
vidual MT providers does vary between different regions
and this is likely due to a number of factors including
variation in public access, healthcare funding and avail-
ability of MT providers. For example, the use of physio-
therapy for some headache types may be relatively
higher in parts of Europe [20, 60] while the use of chiro-
practors for some headache types may be relatively
higher in Australia and the USA [19, 21]. Overall, the
prevalence use of MT for headache appears to be sub-
stantial and likely to be the most common type of phys-
ical therapy utilized for headache in many countries
[19–21, 49]. More high quality epidemiological studies
are needed to measure the prevalence of MT use across
different headache types and sub-types, both within the
general population and clinical populations.
Beyond prevalence, data is more limited regarding
who, how and why headache patients seek MT. From
the information available however, the healthcare needs
of MT headache patients may be more complex and
multi-disciplinary in nature compared to those under
usual medical care alone. Socio-demographic findings
suggest that users of MT and other complementary and
alternative therapies have a higher level of headache dis-
ability and chronicity compared to non-users. This find-
ing may correlate with the higher prevalence of MT
users within headache-clinic populations and a history of
more medical appointments. This may also have implica-
tions for future MT trial designs both in terms of the selec-
tion of trial subjects from inside versus outside MT clinical
settings and the decision to test singular MT interventions
versus MT in combination with other interventions.
Limited information suggests that a pluralistic ap-
proach toward the use of medical and non-medical
headache treatments such as MT is common. While
findings suggest MT is sought most often for reasons of
seeking headache relief, the evidence to support the effi-
cacy of MT for headache relief is still limited. MT pro-
viders must remain mindful of the quality of the
evidence for a given intervention for a given headache
disorder and to inform patients where more effective or
safer treatment interventions are available. More re-
search is needed to assess these therapies individually
and through multimodal approaches and for studies to
include long-term follow-up.
Information limited to Italy, suggests referral from
GPs for MT headache treatment can be common in
some regions, while this is less likely to widespread given
the issue of patient non-disclosure to medical doctors
regarding the use of this treatment in other studies. High
quality healthcare requires open and transparent commu-
nication between patients and providers and between the
providers themselves. Non-disclosure may adversely influ-
ence medical management should unresponsive patients
require further diagnostic investigations [80] or the imple-
mentation of more effective approaches to headache man-
agement [81] or prevents discussion in circumstances
where MT may be contraindicated [82]. Primary headache
providers may benefit from paying particular attention to
the possibility of non-disclosure of non-medical headache
treatments. Open discussion between providers and
patients about the use of MT for headache and the associ-
ated outcomes may improve overall patient care.
Future research
Despite the strong need for more high quality research
to assess the efficacy of MT as a treatment for headache,
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the substantial use of MT brings attention to the need
for more public health and health services research within
this area of headache management. The need for this type
of research was identified in a recent global report on the
use of headache-related healthcare resources [18]. Fur-
thering this information can lead to improvements in
healthcare policy and the delivery of healthcare services.
The substantial use of physical therapies such as MT
has been under-reported within many of the national
surveys reporting headache-related healthcare utilization
[3, 5, 83–85]. Regardless, the role of physical therapies
in headache management continues to be assessed, often
within mainstream and integrated headache manage-
ment settings [86–89]. Continuing this research may fur-
ther our understanding of the efficacy and outcomes
associated with a more multidisciplinary approach to
headache management.
Further to this is the need for more research to under-
stand the healthcare utilization pathways associated with
those patients who use MT in their headache manage-
ment. Little is known about the sociodemographic back-
ground, types of headaches, level of headache disability
and comorbidities more common to this patient popula-
tion. In turn, such information can provide insights that
may be valuable to provider clinical decision-making
and provider education.
Limitations
The design and findings of our review has a number of
limitations. The design of the review was limited by a
search within English language journals only. As a result,
some research on this topic may have been missed.
While the quality scoring system adopted for this review
requires further validation, the data we collected was
limited by the low to moderate quality of available
papers which averaged 6.4 out of 10 points (Table 3).
The low scoring was largely due to significant methodo-
logical issues and the small sample size associated with
much of the collected papers. Much of the data on this
topic was heterogeneous in nature (telephone, postal
surveys and face-to-face interviews). There was a lack of
validated practitioner and patient questionnaires to
report findings, such as for questions on prevalence,
where the time frames utilized varied between ‘currently’,
‘last 12 months’ and ‘ever’.
Data on the prevalence of MT use for headache was
limited particularly within individual MT provider popu-
lations when compared to data found within the general
population and headache-clinic populations. Many stud-
ies assessed the use of MT for headache without identi-
fying headache types. Only one study inside an MT
population had reported the percentage of patients
attending for reasons of migraine alone (osteopathy).
The prevalence of MT use for headache was reported
most within chiropractic patient population studies,
however information was limited on the types of head-
ache. We found no studies reporting the prevalence of
headache patients within physiotherapy or massage ther-
apy patient populations using our search terms.
A lack of data for some themes necessitated providing
findings pooled with users of other non-medical head-
ache providers. Data within many geographical regions
was very limited with the most limited data was on the
source of referral to MT headache providers (three
papers from Italy only). These limitations support the
call for more research to be focused exclusively within
MT populations and different regional areas before
stronger conclusions can be drawn.
Conclusion
The needs of those with headache disorders can be com-
plex and multi-disciplinary in nature. Beyond clinical re-
search, more high quality public health and health
services research is needed to measure and examine a
number of issues of significance to the delivery and use
of MT’s within headache management. With unmet
needs still remaining for many who suffer recurrent
headaches, clinicians should remain cognizant of the use
of MT’s and remain open to discussing this approach to
headache management in order to ensure greater safety,
effectiveness and coordination of headache care.
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